Stability of venlafaxine immediate-release suspensions

International Journal of Pharmaceutical Compounding

Volumn 15, Issue 1, 2011, Pages 81-84

  Donnelly, Ronald F ^a   Wong, Keith ^b   Goddard, Rob ^a   Johanson, Christel ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSPHERE; VENLAFAXINE;

ARTICLE; DRUG DETERMINATION; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG STORAGE; EXTENDED DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMEDIATE DRUG RELEASE; PH; PHYSICAL CHEMISTRY; PLASTIC BOTTLE; POWDER; STORAGE TEMPERATURE; SUSPENSION; SYRUP;

EID: 79251478046     PISSN: 10924221     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Muth EA, Haskins JT, Mover JA et al. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cylcohexanol derivative. Biochem Pharmacol 1986; 35(24): 4493-4497.
2. Muth EA, Moyer JA, Haskins JT et al. Biochemical, neurophysiological, and behavioral effects of Wy-45,223 and other identified metabolites of the antidepressant venlafaxine. Drug Dev Res 1991; 23(2): 191-199.
3. Wei Z, Bing-Ren X, Cai-Yun W. Liquid chromatography-mass spectrometry method for the determination of venlafaxine in human plasma and application to a pharmacokinetic study. Biomed Chromatogr 2007; 21(3): 266-272. (Pubitemid 46477467)